Cochrane Abstracts
Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic cervical cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Vascular Endothelial Growth Factor (VEGF) Targeting Therapy for Persistent, Recurrent, or Metastatic Cervical Cancer." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435728/all/Vascular_endothelial_growth_factor__VEGF__targeting_therapy_for_persistent__recurrent__or_metastatic_cervical_cancer.
Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic cervical cancer. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435728/all/Vascular_endothelial_growth_factor__VEGF__targeting_therapy_for_persistent__recurrent__or_metastatic_cervical_cancer. Accessed December 8, 2024.
Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic cervical cancer. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435728/all/Vascular_endothelial_growth_factor__VEGF__targeting_therapy_for_persistent__recurrent__or_metastatic_cervical_cancer
Vascular Endothelial Growth Factor (VEGF) Targeting Therapy for Persistent, Recurrent, or Metastatic Cervical Cancer [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435728/all/Vascular_endothelial_growth_factor__VEGF__targeting_therapy_for_persistent__recurrent__or_metastatic_cervical_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic cervical cancer
ID - 435728
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435728/all/Vascular_endothelial_growth_factor__VEGF__targeting_therapy_for_persistent__recurrent__or_metastatic_cervical_cancer
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
